Centre Hospitalier Tarbes-Lourdes

The Centre Hospitalier Tarbes-Lourdes is active in cancer and blood disorder research, with studies focused on neoplasms, multiple myeloma, colon cancer, and lung cancer. These trials are largely designed to test new treatment strategies, refine maintenance approaches, and improve long-term disease control for patients.

• New treatment combinations and maintenance strategies for multiple myeloma
• Adjuvant and postoperative care studies in colon carcinoma and advanced colorectal disease
• Evaluation of treatment effectiveness in metastatic non-squamous lung cancer

Overall, this research aims to improve response rates, reduce relapse, and support more personalized care for patients treated at the site.

Several trials at this hospital examine digestive system diseases, especially colon cancer, colon carcinoma, and advanced disease involving the peritoneum or rectum. The main goal is to compare treatment options that may strengthen disease-free survival and help guide adjuvant therapy decisions.

• Strategies for advanced colon cancer with peritoneal metastases
• Post-surgery treatment approaches for older patients with stage III colon cancer
• Use of circulating tumor DNA to improve decision-making in colon cancer

These studies reflect a strong interest in improving outcomes after surgery and identifying which patients are most likely to benefit from additional treatment.

Research in immune system diseases includes studies of Giant Cell Arteritis and severe allergic conditions. These trials are designed to compare established therapies, assess treatment withdrawal, and better understand how to maintain disease control over time.

• Comparing treatment options for Giant Cell Arteritis
• Evaluating whether stopping tocilizumab or dupilumab remains safe in controlled patients
• Supporting long-term management of severe asthma and related inflammatory disease

This area highlights a focus on balancing effectiveness with treatment burden, especially for patients who are already stable on therapy.

Clinical research in respiratory tract diseases at Centre Hospitalier Tarbes-Lourdes includes work on severe asthma and well controlled severe allergic asthma. The trials are mainly exploring whether treatment can be safely reduced or withdrawn without increasing flare-ups.

• Testing whether omalizumab can be stopped without worsening asthma control
• Assessing the safety of dupilumab withdrawal in stable patients
• Improving long-term management of severe allergic airway disease

These studies are aimed at preserving control of chronic respiratory disease while limiting unnecessary ongoing treatment.

The site also conducts smaller studies across bacterial infections and mycoses, musculoskeletal diseases, and supportive clinical techniques. These include research on bartonellosis, cat scratch disease, and meniscal pain of degenerative origin, with a focus on symptom relief and better clinical outcomes.

• Treating suppurative cat scratch disease and related lymph node infection
• Relieving degenerative meniscal pain through targeted local treatment
• Exploring supportive and diagnostic approaches in mixed clinical settings

These studies broaden the research portfolio beyond oncology and reflect interest in practical treatments that may improve everyday patient care.